Recruiting Leukemia Studies in Capital Federal
About Leukemia Clinical Trials in Capital Federal
Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.
There are currently 1 leukemia clinical trials recruiting participants in Capital Federal, . These studies are seeking a combined 347 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Leukemia Clinical Trials in Capital Federal — FAQ
Are there leukemia clinical trials in Capital Federal?
Yes, there are 1 leukemia clinical trials currently recruiting in Capital Federal, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Capital Federal?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Capital Federal research site will contact you about next steps.
Are clinical trials in Capital Federal free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Capital Federal studies also compensate for your time and travel.
What leukemia treatments are being tested?
The 1 active trials in Capital Federal are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.
Data updated March 2, 2026 from ClinicalTrials.gov